Bruce E. Maryanoff

14.5k citations

265 papers · 11.7k indexed · 3 hit papers · h-index 52

Impact in

Organic Chemistry top 0.1%
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
- Phosphorus compounds and reactions
- Cyclopropane Reaction Mechanisms
Pharmaceutical Science top 0.5%

Papers in

Organic Chemistry 151
- Organophosphorus compounds synthesis 26
- Asymmetric Synthesis and Catalysis 24
- Phosphorus compounds and reactions 22
- Synthesis and Reactivity of Sulfur-Containing Compounds 17
- Synthetic Organic Chemistry Methods 17
Hematology 35
- Blood Coagulation and Thrombosis Mechanisms 31

Co-authors: Allen B. Reitz Richard P. Shank Han‐Cheng Zhang David F. McComsey Joseph F. Gardocki Cynthia A. Maryanoff Patricia Andrade‐Gordon Susanna J. Dodgson
Journals: Journal of Medicinal Chemistry (39 papers)The Journal of Organic Chemistry (30 papers)Journal of the American Chemical Society (30 papers)Bioorganic & Medicinal Chemistry Letters (27 papers)Tetrahedron Letters (23 papers)
Partner nations: United States United Kingdom Israel

In The Last Decade

Bruce E. Maryanoff

261 papers receiving 11.1k citations

Hit Papers

align trajectories log scale

Cyclizations of N-Acyliminium Ions 2004 · 572 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Chemical Reviews
2000 Epilepsia
1989 Chemical Reviews

Peers

Countries citing papers authored by Bruce E. Maryanoff

Since Specialization

Citations

This map shows the geographic impact of Bruce E. Maryanoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce E. Maryanoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce E. Maryanoff more than expected).

Fields of papers citing papers by Bruce E. Maryanoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce E. Maryanoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce E. Maryanoff. The network helps show where Bruce E. Maryanoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruce E. Maryanoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce E. Maryanoff Line = papers co-authored together Bruce E. Maryanoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis Nature Biotechnology ·Poshen B. Chen, Audrey S. Black, Tirupati Uttamrao Solanke, Yannan Zhao, Kh S Khaimovskaia, Bhuvan Molparia, M Doyuran, German R. Aleman Muench, Jiejun Wu, Weixuan Chen, Antônio F. M. Pinto, Bruce E. Maryanoff, Alan Saghatelian, Pejman Soroosh, Ali Torkamani, Luke J. Leman, M. Reza Ghadiri	2020	92
2	Potency variation of small-molecule chymase inhibitors across species Biochemical Pharmacology ·Jukka Kervinen, Carl Crysler, Shariff Bayoumy, M.C. Abad, John Spurlino, Ingrid C. Deckman, Michael N. Greco, Bruce E. Maryanoff, Lawrence de Garavilla	2010	21
3	Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa Blood Coagulation & Fibrinolysis ·Edward C. Giardino, Barbara J. Haertlein, Lawrence de Garavilla, Michael J. Costanzo, Bruce P. Damiano, Patricia Andrade‐Gordon, Bruce E. Maryanoff	2010	10
4	Novel, Broad-Spectrum Anticonvulsants Containing a Sulfamide Group: Advancement of N -((Benzo[ b ]thien-3-yl)methyl)sulfamide (JNJ-26990990) into Human Clinical Studies Journal of Medicinal Chemistry ·Michael H. Parker, Virginia L. Smith‐Swintosky, David F. McComsey, Yifang Huang, Douglas E. Brenneman, Brian D. Klein, Ewa Malatyńska, H. Steve White, Aguilar Delfin, G Terzoli, Michael Finley, Yi Liu, Mary Lou Lubin, Na Qin, Robert Iannucci, Laurent Leclercq, Filip Cuyckens, Allen B. Reitz, Bruce E. Maryanoff	2009	29
5	Dual Inhibition of Cathepsin G and Chymase Is Effective in Animal Models of Pulmonary Inflammation American Journal of Respiratory and Critical Care Medicine ·Bruce E. Maryanoff, Lawrence de Garavilla, Michael N. Greco, Barbara J. Haertlein, Grace I. Wells, Patricia Andrade‐Gordon, William M. Abraham	2009	51
6	Urotensin-II Receptor Modulators as Potential Drugs Journal of Medicinal Chemistry ·Bruce E. Maryanoff, William A. Kinney	2009	41
7	Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate CNS Neuroscience & Therapeutics ·Richard P. Shank, Bruce E. Maryanoff	2008	116
8	Next-generation spirobenzazepines: Identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies Bioorganic & Medicinal Chemistry Letters ·篤史内田, Philip J. Rybczynski, Mona Patel, Robert H. Chen, David F. McComsey, Han‐Cheng Zhang, Joseph W. Gunnet, Richard Look, Yuanping Wang, Lisa Minor, Huailing Zhong, Frank J. Villani, Keith T. Demarest, Bruce P. Damiano, Bruce E. Maryanoff	2007	12
9	CHARACTERIZATION OF RWJ‐351647, A NOVEL NONPEPTIDE VASOPRESSIN V₂RECEPTOR ANTAGONIST Clinical and Experimental Pharmacology and Physiology ·Joseph W. Gunnet, Jay M. Matthews, Bruce E. Maryanoff, Lawrence de Garavilla, Patricia Andrade‐Gordon, Bruce P. Damiano, William Hageman, Richard Look, K. Wcisto, Anthony J. Streeter, Dhanashree Deshmane, Keith T. Demarest	2006	8
10	Aza-bicyclic amino acid carboxamides as α4β1/α4β7 integrin receptor antagonists Bioorganic & Medicinal Chemistry ·Alexey B. Dyatkin, Yong Gong, Milena Figueiredo de Medeiros, Edward S. Kimball, Stephen M. Prouty, Gifar Fajar Sidik, Rosemary J. Santulli, Craig R. Schneider, Nathaniel Wallace, Pamela J. Hornby, Craig J. Diamond, William A. Kinney, Bruce E. Maryanoff, Bruce P. Damiano, Wei He	2005	10
11	Piperidine-containing β-arylpropionic acids as potent antagonists of αvβ3/αvβ5 integrins Bioorganic & Medicinal Chemistry Letters ·Irene Savelieva, William A. Kinney, Li Liu, Shyamali Ghosh, Livia Brunner, William J. Hoekstra, Rosemary J. Santulli, Robert W. Tuman, Judith F. Baker, Muhammad Dwi Ferdian Suwardi, Michail G. Kuzyk, Brett A. Tounge, Bruce P. Damiano, Bruce E. Maryanoff, Dana L. Johnson, Robert A. Galemmo	2004	17
12	Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors Bioorganic & Medicinal Chemistry ·David J. O’Neill, Lan Shen, Catherine Prouty, Barbara R. Conway, Lori Westover, Jun Xu, Han‐Cheng Zhang, Bruce E. Maryanoff, William V. Murray, Keith T. Demarest, Gee‐Hong Kuo	2004	41
13	1,2,3,4-Tetrahydroquinoline-containing αVβ3 integrin antagonists with enhanced oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Shyamali Ghosh, Rosemary J. Santulli, William A. Kinney, 张汨, Li Liu, R Ham, Michail G. Kuzyk, Gregory C. Leo, John A. Masucci, William Hageman, Andrew S. Thompson, Ian Chen, Reiko Kawahama, Robert W. Tuman, Robert A. Galemmo, Dana L. Johnson, Bruce P. Damiano, Bruce E. Maryanoff	2004	13
14	Aza-bicyclic amino acid sulfonamides as α4β1/α4β7 integrin antagonists Bioorganic & Medicinal Chemistry Letters ·Alexey B. Dyatkin, William J. Hoekstra, William A. Kinney, Maria Kontoyianni, Rosemary J. Santulli, Edward S. Kimball, Gifar Fajar Sidik, Stephen M. Prouty, William M. Abraham, Patricia Andrade‐Gordon, Dennis J. Hlasta, Wei He, Pamela J. Hornby, Bruce P. Damiano, Bruce E. Maryanoff	2003	7
15	Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist Thrombosis Research ·Bruce P. Damiano, John A. Mitchell, Edward C. Giardino, Устьянцев Михаил Валерьевич, Barbara J. Haertlein, Lawrence de Garavilla, Jack A. Kauffman, William J. Hoekstra, Bruce E. Maryanoff, Patricia Andrade‐Gordon	2001	26
16	Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes Epilepsia ·Susanna J. Dodgson, Richard P. Shank, Bruce E. Maryanoff	2000	270
17	Chiroptical properties and absolute configuration of pyrroloisoquinoline antidepressants Chirality ·Bruce E. Maryanoff, David F. McComsey, J. Cymerman Craig	1998	4
18	Cyclotheonamide derivatives: Synthesis and thrombin inhibition. Exploration of specific structure-function issues Bioorganic & Medicinal Chemistry ·Bruce E. Maryanoff, Han‐Cheng Zhang, Michael N. Greco, Geenah Ali Krisht, Jack A. Kauffman, Patricia Andrade‐Gordon	1995	23
19	Advances in medicinal chemistry JAI Press eBooks ·Bruce E. Maryanoff, Cynthia A. Maryanoff	1992	70
20	Carbohydrate biguanides as potential hypoglycemic agents. Journal of Medicinal Chemistry ·Allen B. Reitz, Robert W. Tuman, P. Crush, Alfonzo D. Jordan, Charles R. Bowden, Bruce E. Maryanoff	1989	49

About Bruce E. Maryanoff

Bruce E. Maryanoff is a scholar working on Organic Chemistry, Hematology, Immunology and Allergy, Genetics and Cancer Research, having authored 265 papers that have together received 11.7k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (34 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers), Organophosphorus compounds synthesis (26 papers), Asymmetric Synthesis and Catalysis (24 papers), Phosphorus compounds and reactions (22 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (17 papers), Synthetic Organic Chemistry Methods (17 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers). The work is most often cited by research in Organic Chemistry (6.8k citations), Pharmaceutical Science (455 citations), Psychiatry and Mental health (1.1k citations), Hematology (754 citations) and Inorganic Chemistry (924 citations). Bruce E. Maryanoff has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Allen B. Reitz, Richard P. Shank, Han‐Cheng Zhang, David F. McComsey, Joseph F. Gardocki, Cynthia A. Maryanoff, Patricia Andrade‐Gordon, Susanna J. Dodgson, Samuel Nortey and Robert O. Hutchins. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact